Patent · US Active

NPR-B agonists

US8546523B2 · kind B2 · utility

6Cited by

4References

3Claims

0Family size

Assignee

Alcon Research, Ltd. · US

Inventors

Frank Osterkamp · Berlin, DE
Heiko Hawlisch · Berlin, DE
Gerd Hummel · Berlin, DE
Tobias Knaute · Berlin, DE
Ulf Reimer · Berlin, DE
Ulrich Reineke · Berlin, DE
Uwe Richter · Berlin, DE
Bernadett Simon · Bonn, DE
Edgar Specker · Berlin, DE
Markus Woischnik · Berlin, DE
Mark R. Hellberg · Arlington, US

Key dates

Filing date	Sep 23, 2010
Grant date	Oct 1, 2013
Priority date	—
Expiry date	Mar 30, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K7/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.